Patent details
EP3529360 Title: METHODS FOR PREVENTING CARDIOVASCULAR EVENTS THROUGH PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) PROTEIN REDUCTION
Basic Information
- Publication number:
- EP3529360
- PCT Application Number:
- US2017057218
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178009767
- PCT Publication Number:
- WO2018075658
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS FOR PREVENTING CARDIOVASCULAR EVENTS THROUGH PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) PROTEIN REDUCTION
- French Title of Invention:
- PROCÉDÉS DE PRÉVENTION D'ÉVÉNEMENTS CARDIOVASCULAIRES PAR RÉDUCTION PROTÉIQUE DE LA PROPROTÉINE CONVERTASE SUBTILISINE KEXINE 9 (PCSK9)
- German Title of Invention:
- VERFAHREN ZUR VORBEUGUNG VON KARDIOVASKULÄREN EREIGNISSEN DURCH PROTEINREDUKTION VON PROPROTEIN-KONVERTASE-SUBTILISIN-KEXIN 9 (PCSK9)
- SPC Number:
Dates
- Filing date:
- 18/10/2017
- Grant date:
- 17/04/2024
- EP Publication Date:
- 28/08/2019
- PCT Publication Date:
- 26/04/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/04/2024
- EP B1 Publication Date:
- 17/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/10/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/04/2024
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- WIJNGAARD, Peter
- Address:
- United States (US)
2
- Name:
- KALLEND, David
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662409816 P
- Priority Date:
- 18/10/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201662422028 P
- Priority Date:
- 14/11/2016
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762472525 P
- Priority Date:
- 16/03/2017
- Priority Country:
- United States (US)
4
- Priority Number:
- 201762550426 P
- Priority Date:
- 25/08/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 15/113; A61K 31/713;
Publication
European Patent Bulletin
1
- Issue number:
- 202416
- Publication date:
- 17/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202508
- Publication date:
- 19/02/2025
- Description:
- Opposition procedure started
3
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/10/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|